Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3)

 REVIEWS 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):225-35

The present and future role of 111In Pentetreo-tide in the PET era

Rambaldi P. F., Cuccurullo V., Briganti V., Mansi L.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):237-44

99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors

Gabriel M., Muehllechner P., Decristoforo C., von Guggenberg E., Kendler D., Promegger R., Profanter C., Moncayo R., Virgolini I.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):245-51

Lymphoscintigraphy with intraoperative gamma probe sentinel node detection: clinical impact in patients with head and neck melanomas

Maccauro M., Villano C., Aliberti G., Ferrari L., Castellani M. R., Patuzzo R., Tshering D., Santinami M., Bombardieri E.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):253-7

The prognostic value of FDG PET in head and neck cancer. Correlation with histopathology

Döbert N., Kovács A. F., Menzel C., Hamscho N., Yuen Yuen H., Engels K., Walendzik H., Grünwald F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):259-66

Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer

Messa C., Ceresoli G. L., Rizzo G., Artioli D., Cattaneo M., Castellone P., Gregorc V., Picchio M., Landoni C., Fazio F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):267-79

Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy

Rizzo G., Castiglioni I., Arienti R., Cattaneo G. M., Landoni C., Artioli D., Gilardi M. C., Messa C., Reni M., Ceresoli G. L., Fazio F.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):281-5

Washout of [99mTc] sestamibi in predicting response to chemotherapy in patients with multiple myeloma

Pace L., Catalano L., Del Vecchio S., De Renzo A., Fonti R., Salvatore B., Andretta C., Di Nuzzo C., Rotoli B., Salvatore M.


 ORIGINAL ARTICLES 

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 September;49(3):287-96

Tomographic evaluation of [131I] 6β-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas

Imperiale A., Olianti C., Mannelli M., La Cava G., Pupi A.


top of page